ICYMI: James Sabry just signed off on a landmark first for Roche’s dealmaking crew

Bioregnum Opinion Column by John Carroll

James Sabry’s BD team in Roche has a long track record in hunting the globe for new biotech deals. But they’ve never journeyed into China before to ink a worldwide development and commercialization pact with a China-based biotech...

Click to view original post